(Q43748644)

26 November 2017

title

Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies (English)

1 reference

non-small-cell lung carcinoma

26 November 2017

main subject

1 reference

8

Manfred Dietel

1 reference

26 November 2017

Arne Warth

1

1 reference

26 November 2017

Roland Penzel

2

1 reference

26 November 2017

Regine Brandt

3

1 reference

26 November 2017

Christine Sers

4

1 reference

26 November 2017

Jürgen R Fischer

5

1 reference

26 November 2017

Michael Thomas

6

1 reference

26 November 2017

Felix J F Herth

7

1 reference

26 November 2017

Peter Schirmacher

9

1 reference

26 November 2017

Hendrik Bläker

10

1 reference

26 November 2017

publication date

15 March 2012

1 reference

26 November 2017

1 reference

26 November 2017

volume

460

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

407-414

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-012-1219-x

26 November 2017

exact match

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Screening for epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Non-small-cell lung cancer third-line therapy with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

KRAS gene mutations in lung cancer: particulars established and issues unresolved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

KRAS mutations in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

EGFR mutation detection in NSCLC--assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1219-X

Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22419261

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22419261

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00428-012-1219-X

1 reference

Dimensions Publication ID

26 November 2017

1031476499

0 references

Fatcat ID

release_cm6wz2xle5egvj2cmmq37tbxnq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cm6wz2xle5egvj2cmmq37tbxnq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference